Neurogenic Detrusor Overactivity
📧 Sign up to get email alerts when something new happens for Neurogenic Detrusor Overactivity.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-05-09Clinical Trial Update: Optimization of OnabotulinumtoxinA (BTX-A) Injection for the Treatment of Neurogenic Lower Urinary Tract Dysfunction [NA]
A completed clinical trial evaluating optimized injections of OnabotulinumtoxinA for neurogenic lower urinary tract dysfunction has posted r…
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron Oral Suspension in Pediatric Subjects From 3 to Less Than 12 Years of Age With Neurogenic Detrusor Overactivity (NDO) or Overactive Bladder (OAB) [Phase 1]
This completed Phase 1 pediatric study assessed the pharmacokinetics, safety, and tolerability of Mirabegron oral suspension in children age…
-
CLINICAL_TRIALS trial_result · 2024-10-22Clinical Trial Update: Single Dose Study to Measure Blood Levels and Safety of a Drug for Children With Overactive Bladder [Phase 1]
Phase 1 single-dose pediatric trial to measure blood levels and safety of a drug for overactive bladder and neurogenic detrusor overactivity…
-
CLINICAL_TRIALS trial_result · 2024-10-22Clinical Trial Update: A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron OCAS (Oral Controlled Absorption System) in Pediatric Subjects With Neurogenic Detrusor Overactivity or Overactive Bladder [Phase 1]
Phase 1 study assessing pharmacokinetics, safety and tolerability of Mirabegron OCAS in pediatric patients with Neurogenic Detrusor Overacti…
-
CLINICAL_TRIALS trial_result · 2022-06-09Clinical Trial Update: A Two-week Open-label Pharmacodynamic and Pharmacokinetic Study of Multiple Doses of a Darifenacin Liquid Oral Suspension in Children (2 - 15 Years) With Neurogenic Detrusor Overactivity [Phase 2]
Phase 2 open-label pharmacodynamic/pharmacokinetic study of multiple doses of darifenacin liquid suspension in children with neurogenic detr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-06-16Clinical Trial Update: Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 1 [Phase 3]
Phase 3 clinical trial investigating Dysport for urinary incontinence due to neurogenic detrusor overactivity related to spinal cord injury …
-
CLINICAL_TRIALS trial_result · 2021-06-16Clinical Trial Update: Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 2 [Phase 3]
A Phase 3 study evaluating Dysport (abobotulinumtoxinA) for urinary incontinence due to neurogenic detrusor overactivity in adults with spin…
-
CLINICAL_TRIALS trial_result · 2021-01-29Clinical Trial Update: Effects of Rec 0/0438 in Patients With Neurogenic Detrusor Overactivity Due to Spinal Cord Injury [Phase 1, Phase 2]
Phase 1/2 trial updates for Rec 0/0438 in neurogenic detrusor overactivity due to spinal cord injury completed.
-
CLINICAL_TRIALS trial_result · 2020-10-26Clinical Trial Update: Open-label Long-term Extension Study of Fesoterodine in Japanese Subjects With Neurogenic Detrusor Overactivity. [Phase 3]
Open-label long-term extension study of fesoterodine in Japanese subjects with neurogenic detrusor overactivity completed; results posted.
-
CLINICAL_TRIALS trial_result · 2020-05-12Clinical Trial Update: Open-label Phase 3 Study With Mirabegron in Children From 3 to Less Than 18 Years of Age With Neurogenic Detrusor Overactivity [Phase 3]
Open-label Phase 3 trial of mirabegron in children aged 3 to less than 18 with neurogenic detrusor overactivity completed; results were post…
-
CLINICAL_TRIALS trial_result · 2020-05-12Clinical Trial Update: A Long-Term Extension Study of OnabotulinumtoxinA (BOTOX®) for Urinary Incontinence Due to Neurogenic Detrusor Overactivity [Phase 3]
A long-term extension study of onabotulinumtoxinA (BOTOX) for urinary incontinence due to neurogenic detrusor overactivity has completed Pha…
-
CLINICAL_TRIALS trial_result · 2019-12-26Clinical Trial Update: Botox for Neurogenic Detrusor Overactivity and the Prevention of Autonomic Dysreflexia Following SCI [Phase 4]
Phase 4 clinical trial update investigating Botox for neurogenic detrusor overactivity and prevention of autonomic dysreflexia after spinal …
-
CLINICAL_TRIALS trial_result · 2019-10-30Clinical Trial Update: Study of OnabotulinumtoxinA (BOTOX®) for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients [Phase 3]
Phase 3 clinical trial evaluating onabotulinumtoxinA (BOTOX) for urinary incontinence due to neurogenic detrusor overactivity in pediatric p…
-
CLINICAL_TRIALS trial_result · 2019-05-06Clinical Trial Update: A Study to Assess the Long Term Effect, Safety and Metabolism of a Solifenacin Liquid Suspension in Participants 5 to 18 Years of Age With Neurogenic Detrusor Overactivity [Phase 3]
Phase 3 trial completed evaluating the long-term safety, tolerability, and metabolism of a solifenacin liquid suspension in children aged 5 …
-
CLINICAL_TRIALS trial_result · 2018-06-21Clinical Trial Update: A Clinical Study to Investigate How Solifenacin Fluid is Taken up, How Long it Stays in the Body and How Effective and Safe it is in Treating Children Aged From 6 Months to Less Than 5 Years With Symptoms of Neurogenic Detrusor Overactivity (NDO) [Phase 3]
Phase 3 pediatric trial evaluating pharmacokinetics, safety, and efficacy of solifenacin for neurogenic detrusor overactivity in children ag…
-
CLINICAL_TRIALS trial_result · 2018-03-26Clinical Trial Update: A Safety and Efficacy Study of BOTOX® (Botulinum Toxin Type A) in Patients With Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in India
This clinical trial update reports on a safety and efficacy study of BOTOX (botulinum toxin type A) for urinary incontinence due to neurogen…
-
CLINICAL_TRIALS trial_result · 2017-12-15Clinical Trial Update: Study of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence From Neurogenic Detrusor Overactivity in Belgium
A completed clinical trial evaluating Botulinum Toxin Type A (BOTOX) for urinary incontinence due to neurogenic detrusor overactivity in Bel…
-
CLINICAL_TRIALS trial_result · 2017-03-13Clinical Trial Update: Effect of Botulinum Toxin A on Neurogenic Detrusor Overactivity in Chronic Spinal Cord Injured Patients
This clinical trial update reports on the completed study evaluating the effect of Botulinum Toxin A on neurogenic detrusor overactivity in …
-
CLINICAL_TRIALS trial_result · 2016-09-22Clinical Trial Update: Evaluation of Safety and Efficacy of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in Korea
A completed Korea-based clinical trial evaluated the safety and efficacy of botulinum toxin type A (BOTOX) for urinary incontinence due to n…
-
CLINICAL_TRIALS trial_result · 2015-11-17Clinical Trial Update: Is the Nerve Growth Factor (NGF) a Useful Biomarker in Neurogenic Bladder Dysfunction After Spinal Cord Injury?
This clinical trial update discusses whether nerve growth factor (NGF) can serve as a biomarker for neurogenic bladder dysfunction after spi…
-
CLINICAL_TRIALS trial_result · 2015-03-24Clinical Trial Update: NEUROTOX: Two Dosages of Type A Botulinic Toxin in Neurogenic Overactive Bladder [Phase 2]
Phase 2 trial testing two doses of botulinum toxin type A for neurogenic overactive bladder was terminated.
-
CLINICAL_TRIALS trial_result · 2014-12-02Clinical Trial Update: Study of Darifenacin in Patients Suffering From Multiple Sclerosis and Neurogenic Detrusor Overactivity [Phase 2]
Phase 2 study of darifenacin in patients with multiple sclerosis and neurogenic detrusor overactivity was terminated.
-
CLINICAL_TRIALS trial_result · 2014-11-06Clinical Trial Update: The Interest of the Nitrous Oxide During Intravesical Injection of Botulinum Toxin A [Phase 3]
This report covers a Phase 3 trial evaluating nitrous oxide as an analgesic aid during intravesical injections of botulinum toxin A. The stu…
-
CLINICAL_TRIALS trial_result · 2014-10-09Clinical Trial Update: Study to Determine Pharmacodynamic Effects and Pharmacokinetics of KUC 7483 CL in Patients With Spinal Cord Injury and Neurogenic Detrusor Overactivity [Phase 1]
Phase 1 pharmacodynamic and pharmacokinetic study of KUC 7483 CL in patients with spinal cord injury and neurogenic detrusor overactivity; s…
-
CLINICAL_TRIALS trial_result · 2014-09-01Clinical Trial Update: Neurogenic Detrusor Overactivity Following Spinal Cord Injury or Multiple Sclerosis [Phase 2]
Phase 2 clinical trial update on neurogenic detrusor overactivity after spinal cord injury or multiple sclerosis; results posted in 2014.